8 Further, recommendations published by the European Alliance of Associations for Rheumatology (EULAR) for the management of PsA with pharmacological therapies include maximizing HRQOL as a main treatment goal for patients
doi: 10.3389/fpls.2025.1646314 Received 13 June 2025 Revised 05 November 2025 Accepted 20 November 2025 Published 23 January 2026 Volume 16 - 2025 Edited by Dilip Kumar, Academy of Sciences of the Czech Republic (ASCR), Czechia Reviewed by Muhammad Zahid Ihsan, Islamia University, Pakistan Michel Havaux, Commissariat lEnergie Atomique et aux Energies Alternatives (CEA), France Updates Copyright 2026 Lachica, Basnet, Laurena, Ocampo and Choi
Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimers disease
Q: What is liposomal glutathione and why does it matter
Sermorelin and GHRP combinations Growth hormone releasing peptides like ipamorelin activate ghrelin receptors, providing additive effects when combined with sermorelin's GHRH activation
References: Dirty Genes - The Histamine Workbook , Dr